ITCI

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Intra-Cellular Therapies (ITCI) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ITCI is expected to report earnings to fall 77.84% to -5 cents per share on February 26

Intra-Cellular Therapies ITCI Stock Earnings Reports

Q4'24

Est.

$-0.06

Q3'24

Missed

by $0.07

Q2'24

Beat

by $0.03

Q1'24

Beat

by $0.16

Q4'23

Beat

by $0.15

The last earnings report on October 30 showed earnings per share of -25 cents, missing the estimate of -18 cents. With 616.36K shares outstanding, the current market capitalization sits at 6.70B.

View a ticker or compare two or three

Compare

ITCI

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ITCI
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for ITCI (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a biopharmaceutical company

Industry PharmaceuticalsOther

Profile

Fundamentals

Details

Industry

Biotechnology

Address

430 East 29th Street

Phone

+1 646 440-9333

Employees

610

Web

https://www.intracellulartherapies.com